Delivery Order SPE2DB24D2205-SPE2DB24FEAFU
Award Date
9/23/24
Potential Completion Date
9/24/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,307,107 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. The $5,284.09 firm-fixed-price contract has a completion date of November 4, 2024 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,262.36, is a delivery order for 4,567,154,351 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. The contract has a completion date of February 5, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,247,518 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules, a critical pharmaceutical product used in the prevention and treatment of influenza. The contract has a total ceiling value of $1,035.40 and a period of performance through February 13, 2025. It...
This is a $5,791.10 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,475,116 units of 75 mg Oseltamivir Phosphate capsules, a medication used to treat influenza. The contract has a performance period through March 6, 2025 and was awarded on March 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999...
This federal contract award is a delivery order valued at $1,494.60 placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of 4,563,471,961 units of the drug Oseltamivir Phosphate 75 mg capsules, an antiviral medication used to treat and prevent influenza. The contract has an ultimate completion date of January 30, 2024 and was awarded on January 29, 2024. It is a firm fixed-price contract with no set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Oseltamivir Phosphate 75 mg capsules. The contract has a ceiling value of $1,594.56 and a final completion date of February 4, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,987.17 firm fixed-price delivery order is for the purchase of 4,567,104,683 units of Oseltamivir Phosphate 75mg capsules, a medication used to treat influenza. The contract has an ultimate completion date of January 31, 2025 and was awarded on January 30, 2025. Amerisourcebergen holds a $999,999,999 Indefinite...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Oseltamivir Phosphate 75 mg capsules. The contract has a total ceiling value of $2,129.64 and is a firm fixed-price delivery order with a completion date of January 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,087.36, is for the procurement of 4,567,218,221 units of Oseltamivir Phosphate 75 mg Capsules. The contract has a period of performance through February 11, 2025 and was awarded on February 10, 2025. This order is placed against AmerisourceBergen's existing Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,558,583 units of Oseltamivir Phosphate 75 mg capsules, with a ceiling value of $1,139.83. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...